WuXi Biologics commenced construction of a new 69 million integrated manufacturing centre for innovative biologics at Chengdu, Southwest China.
The innovative biologics manufacturing centre is to get constructed in 1.3 million square feet in Chengdu.
This facility is going to be the 12th drug substances manufacturing facility (MFG12) for WuXi Biologics.
The new facility will include drug development and commercial manufacturing facilities with an initial bioreactor capacity of 69 million.
WuXi Biologics will apply its extensive expertise as well as a well-established quality system that conforms to the highest international standards at this new integrated manufacturing centre.
The new construction will enable more global partners, create more jobs for local talents, stimulate high growth of the biologics industry in Chengdu as well as accelerate the biologics ecosystem in Southwest China.
|Chengdu, Southwest China